DNA Damage Repair
DNA是合成任意生物的基因信息的载体。DNA中修复的基因编码对于亚细胞放大可见的过程和生物总体功能至关重要。尽管如此，DNA一直受到内来源的损伤，比如：水解、氧化、烷基化或复制错误。另外，电离辐射、紫外线辐射和过多的化学试剂已经成为威胁DNA完整性的外部因素。
与RNA和蛋白不一样的是，DNA受损后不能降解重新合成。而是存在多种修复途径来确保DNA仍然保持完好。在1974年，弗朗西斯·克里克注意到“在DNA修复中，我们完全漏掉了酶可能的作用。我后来意识到DNA很珍贵，因此有可能存在多种不同的机制。
到今天这个预言还是适用：参与到DNA修复途径复杂的网络中后，一百多个基因被表征。DNA损伤可以通过六种不同的途径修复，这取决于损伤的类型：化学改性、未合并的核苷酸，通过直接反转（DR）、错配修复（MMR）和核苷酸切除修复机制反转交联。DNA单链断裂通过基本切除修复改善。高诱变DNA双链断裂最后通过多种复杂的途径修复，这些途径依赖于姐妹染色单体（在细胞周期S或G2阶段）的同源重组（HR）或双链断裂两端的非同源末端接合（NHEJ）。在DNA损伤不能及时修复的情况下，专门的DNA聚合酶启动跨损伤合成（TLS），从而防止DNA复制叉停止。造成这些修复途径的组件不工作的突变会导致疾病，比如：着色性干皮病、共济失调毛细血管扩张、范科尼贫血和患癌症的倾向。
另外，对于目前通常利用细胞DNA修复机制的靶向基因组编辑方法来说，这些修复机制受到高度关注。
Download pathway image as PDF
Canonical Non-Homologous End-Joining
XRCC6 (X-Ray Repair Complementing Defective Repair in Chinese Hamster Cells 6):
XRCC5 (X-Ray Repair Complementing Defective Repair in Chinese Hamster Cells 5 (Double-Strand-Break Rejoining)):
PRKDC (Protein Kinase, DNA-Activated, Catalytic Polypeptide):
ATM (Ataxia Telangiectasia Mutated):
TRIM29 (Tripartite Motif Containing 29):
ATR (Ataxia Telangiectasia and Rad3 Related):
H2AFX (H2A Histone Family, Member X):
XRCC4 (X-Ray Repair Complementing Defective Repair in Chinese Hamster Cells 4):
LIG4 (Ligase IV, DNA, ATP-Dependent):
NHEJ1 (Nonhomologous End-Joining Factor 1):
APTX - Aprataxin:
APLF (Aprataxin and PNKP Like Factor):
DCLRE1C (DNA Cross-Link Repair 1C):
PNKP (Polynucleotide Kinase 3'-Phosphatase):
POLL (Polymerase (DNA Directed), lambda):
POLM (Polymerase (DNA Directed), mu):
MRE11A - Mre11:
RAD50 (RAD50 Homolog (S. Cerevisiae)):
TP53BP1 (Tumor Protein P53 Binding Protein 1):
Microhomology-Mediated End-Joining
PARP1 (Poly (ADP-Ribose) Polymerase 1):
LIG3 (Ligase III, DNA, ATP-Dependent):
LIG2 - Ligase II, DNA, ATP-Dependent:
PARP2 (Poly (ADP-Ribose) Polymerase 2):
LIG1 (Ligase I, DNA, ATP-Dependent):
ATM (Ataxia Telangiectasia Mutated):
TRIM29 (Tripartite Motif Containing 29):
ATR (Ataxia Telangiectasia and Rad3 Related):
RBBP8 - Retinoblastoma Binding Protein 8:
MRE11A - Mre11:
RAD50 (RAD50 Homolog (S. Cerevisiae)):
WRN - RECQL2:
Homologous Recombination
RAD51 (DNA Repair Protein Homolog 1):
BRCA1 (Breast Cancer 1):
BRCA2 (Breast Cancer 2, Early Onset):
POLE (Polymerase (DNA Directed), Epsilon, Catalytic Subunit):
POLE2 (Polymerase (DNA Directed), epsilon 2 (p59 Subunit)):
POLE3 (Polymerase (DNA Directed), epsilon 3 (p17 Subunit)):
POLE4 (Polymerase (DNA-Directed), epsilon 4 (p12 Subunit)):
POLD1 (Polymerase (DNA Directed), delta 1, Catalytic Subunit 125kDa):
POLD2 (Polymerase (DNA Directed), delta 2, Accessory Subunit):
POLD3 (Polymerase (DNA-Directed), delta 3, Accessory Subunit):
POLD4 (Polymerase (DNA-Directed), delta 4, Accessory Subunit):
ATM (Ataxia Telangiectasia Mutated):
TRIM29 (Tripartite Motif Containing 29):
ATR (Ataxia Telangiectasia and Rad3 Related):
Rad51B - RAD51 Homolog B:
RAD51C (DNA Repair Protein RAD51 Homolog 3):
XRCC2 (X-Ray Repair Complementing Defective Repair in Chinese Hamster Cells 2):
XRCC3 (X-Ray Repair Complementing Defective Repair in Chinese Hamster Cells 3):
BRIP1 (BRCA1 Interacting Protein C-terminal Helicase 1):
BARD1 (BRCA1 Associated RING Domain 1):
RBBP8 - Retinoblastoma Binding Protein 8:
FAM175A - CCDC98:
UIMC1 (Ubiquitin Interaction Motif Containing 1):
MRE11A - Mre11:
RAD50 (RAD50 Homolog (S. Cerevisiae)):
TP53BP1 (Tumor Protein P53 Binding Protein 1):
RPA1 (Replication Protein A1, 70kDa):
RPA2 (Replication Protein A2, 32kDa):
RPA3 (Replication Protein A3, 14kDa):
PALB2 (Partner and Localizer of BRCA2):
TOP3A (Topoisomerase (DNA) III alpha):
RMI1 (Homolog of Yeast RecQ-mediated Genome Instability 1):
RMI2 (RMI2, RecQ Mediated Genome Instability 2):
DNA2 (DNA Replication Helicase 2 Homolog):
WRN - RECQL2:
RAD54L (RAD54-Like):
MUS81 (MUS81 Endonuclease Homolog):
SLX1B - SLX1A/GIYD2:
BTBD12 (BTB (POZ) Domain Containing 12):
GEN1 (Gen Endonuclease Homolog 1):
Single Strand Annealing
MSH2 (Mismatch Repair Protein 2):
ERCC1 (Excision Repair Cross Complementing Polypeptide-1):
MSH3 (MutS Homolog 3):
ERCC4 (Excision Repair Cross-Complementing Rodent Repair Deficiency, Complementation Group 4):
ATM (Ataxia Telangiectasia Mutated):
TRIM29 (Tripartite Motif Containing 29):
ATR (Ataxia Telangiectasia and Rad3 Related):
MRE11A - Mre11:
RAD50 (RAD50 Homolog (S. Cerevisiae)):
RPA1 (Replication Protein A1, 70kDa):
RPA2 (Replication Protein A2, 32kDa):
RPA3 (Replication Protein A3, 14kDa):
RAD52 (RAD52 Homolog (S. Cerevisiae)):
Break-Induced Replication
MRE11A - Mre11:
RAD50 (RAD50 Homolog (S. Cerevisiae)):
MCM2 (Minichromosome Maintenance Complex Component 2):
MCM7 (Minichromosome Maintenance Complex Component 7):
RAD51 (DNA Repair Protein Homolog 1):
RPA1 (Replication Protein A1, 70kDa):
RPA2 (Replication Protein A2, 32kDa):
RPA3 (Replication Protein A3, 14kDa):
MCM3 (Minichromosome Maintenance Complex Component 3):
MCM4 (Minichromosome Maintenance Deficient 4):
MCM5 (Minichromosome Maintenance Complex Component 5):
MCM6 (Minichromosome Maintenance Complex Component 6):
Base Excision Repair
OGG1 (8-Oxoguanine DNA Glycosylase):
UNG (Uracil-DNA Glycosylase):
APEX1 (Apurinic/Apyrimidinic Endonuclease 1):
MPG (N-Methylpurine-DNA Glycosylase):
SMUG1 (Single-Strand-Selective Monofunctional Uracil-DNA Glycosylase 1):
TDG (Thymine-DNA Glycosylase):
MBD4 (Methyl-CpG Binding Domain Protein 4):
MUTYH (MutY Homolog (E. Coli)):
NEIL1 (Endonuclease VIII-Like 1):
NEIL2 (Endonuclease 8-like 2):
NEIL3 (Nei Endonuclease VIII-Like 3):
POLB (Polymerase (DNA Directed), beta):
POLD1 (Polymerase (DNA Directed), delta 1, Catalytic Subunit 125kDa):
POLD2 (Polymerase (DNA Directed), delta 2, Accessory Subunit):
POLD3 (Polymerase (DNA-Directed), delta 3, Accessory Subunit):
POLD4 (Polymerase (DNA-Directed), delta 4, Accessory Subunit):
FEN1 (Flap Structure-Specific Endonuclease 1):
LIG1 (Ligase I, DNA, ATP-Dependent):
Nuleotide Excision Repair
POLR2B (Polymerase (RNA) II (DNA Directed) Polypeptide B, 140kDa):
XPC (Xeroderma Pigmentosum, Complementation Group C):
DDB1 (Damage Specific DNA Binding Protein 1):
XPA (Xeroderma Pigmentosum, Complementation Group A):
RAD23A (RAD23 Homolog A):
RAD23B (RAD23 Homolog B):
CETN2 (Centrin, EF-Hand Protein, 2):
DDB2 (Damage-Specific DNA Binding Protein 2, 48kDa):
ERCC1 (Excision Repair Cross Complementing Polypeptide-1):
ERCC2 (Excision Repair Cross-Complementing Rodent Repair Deficiency, Complementation Group 2):
ERCC3 (DNA Repair Protein Complementing XP-B Cells):
GTF2H1 (General Transcription Factor IIH, Polypeptide 1, 62kDa):
GTF2H4 (General Transcription Factor IIH, Polypeptide 4, 52kDa):
GTF2H3 (General Transcription Factor IIH, Polypeptide 3, 34kD):
GTF2H5 (General Transcription Factor IIH, Polypeptide 5):
CDK7 (Cyclin-Dependent Kinase 7):
RFC1 (Replication Factor C (Activator 1) 1, 145kDa):
RFC2 (Replication Factor C (Activator 1) 2, 40kDa):
RFC3 (Replication Factor C (Activator 1) 3, 38kDa):
RFC4 (Replication Factor C (Activator 1) 4, 37kDa):
RFC5 (Replication Factor C (Activator 1) 5, 36.5kDa):
POLK (Polymerase (DNA Directed) kappa):
ERCC4 (Excision Repair Cross-Complementing Rodent Repair Deficiency, Complementation Group 4):
ERCC5 (DNA Repair Protein Complementing XP-G Cells):
ERCC6 (Excision Repair Cross-Complementing Rodent Repair Deficiency, Complementation Group 6):
ERCC8 (Excision Repair Cross-Complementing Rodent Repair Deficiency, Complementation Group 8):
POLE (Polymerase (DNA Directed), Epsilon, Catalytic Subunit):
POLE2 (Polymerase (DNA Directed), epsilon 2 (p59 Subunit)):
POLE3 (Polymerase (DNA Directed), epsilon 3 (p17 Subunit)):
POLE4 (Polymerase (DNA-Directed), epsilon 4 (p12 Subunit)):
PCNA (Proliferating Cell Nuclear Antigen):
XRCC1 (X-Ray Repair Complementing Defective Repair in Chinese Hamster Cells 1):
FEN1 (Flap Structure-Specific Endonuclease 1):
LIG1 (Ligase I, DNA, ATP-Dependent):
RPA1 (Replication Protein A1, 70kDa):
RPA2 (Replication Protein A2, 32kDa):
RPA3 (Replication Protein A3, 14kDa):
Mismatch Repair
MSH2 (Mismatch Repair Protein 2):
MSH3 (MutS Homolog 3):
MSH6 (MutS Homolog 6 (E. Coli)):
MLH1 (MutL Homolog 1, Colon Cancer, Nonpolyposis Type 2 (E. Coli)):
PMS2 (PMS2 Postmeiotic Segregation Increased 2 (S. Cerevisiae)):
RFC1 (Replication Factor C (Activator 1) 1, 145kDa):
RFC2 (Replication Factor C (Activator 1) 2, 40kDa):
RFC3 (Replication Factor C (Activator 1) 3, 38kDa):
RFC4 (Replication Factor C (Activator 1) 4, 37kDa):
RFC5 (Replication Factor C (Activator 1) 5, 36.5kDa):
POLD1 (Polymerase (DNA Directed), delta 1, Catalytic Subunit 125kDa):
POLD2 (Polymerase (DNA Directed), delta 2, Accessory Subunit):
POLD3 (Polymerase (DNA-Directed), delta 3, Accessory Subunit):
PCNA (Proliferating Cell Nuclear Antigen):
LIG1 (Ligase I, DNA, ATP-Dependent):
RPA1 (Replication Protein A1, 70kDa):
RPA2 (Replication Protein A2, 32kDa):
RPA3 (Replication Protein A3, 14kDa):
EXO1 - Exonuclease 1:
Direct Reversal
MGMT (O6-Methylguanine-DNA-Methyltransferase):
ALKBH1 (AlkB, Alkylation Repair Homolog 1):
ALKBH2 (AlkB, Alkylation Repair Homolog 2):
ALKBH3 (AlkB, Alkylation Repair Homolog 3):
Trans-Lesion Synthesis
POLI (Polymerase (DNA Directed) iota):
POLH (Polymerase (DNA Directed), eta):
REV3L (REV3-Like, Polymerase (DNA Directed), Zeta, Catalytic Subunit):
REV1 (REV1, Polymerase (DNA Directed)):
POLK (Polymerase (DNA Directed) kappa):
PCNA (Proliferating Cell Nuclear Antigen):
FA/BRCA Pathway
BRIP1 (BRCA1 Interacting Protein C-terminal Helicase 1):
ERCC1 (Excision Repair Cross Complementing Polypeptide-1):
BTBD12 (BTB (POZ) Domain Containing 12):
FAN1 (FANCD2/FANCI-Associated Nuclease 1):
CHEK1 (Checkpoint Kinase 1):
FANCI (Fanconi Anemia Complementation Group I):
FANCA (Fanconi Anemia Group A Protein):
FANCG (Fanconi Anemia Complementation Group G):
FANCM (Fanconi Anemia Complementation Group M):
BRCA2 (Breast Cancer 2, Early Onset):
HES1 (Hes Family bHLH Transcription Factor 1):
FANCE (Fanconi Anemia, Complementation Group E):
BLM (Bloom Syndrome RecQ Like Helicase):
BRCA1 (Breast Cancer 1):
FANCL (Fanconi Anemia, Complementation Group L):
EIF2AK2 (Eukaryotic Translation Initiation Factor 2-alpha Kinase 2):
FANCC (Fanconi Anemia, Complementation Group C):
FANCD2 (Fanconi Anemia, Complementation Group D2):
FANCF (Fanconi Anemia, Complementation Group F):
FANCB (Fanconi Anemia, Complementation Group B):
You are here:
